In 2007, The Cancer Council Australia, with co-sponsorship from the Commonwealth Department of Health and Ageing, convened a national roundtable discussion on human papillomavirus (HPV) immunisation and its impact on the National Cervical Screening Program. HPV immunisation has the potential to prevent strains of HPV that cause 70% of cervical cancers. The immunisation program must...

Introduction: Despite increasing immunisation coverage in recent years, pertussis remains a leading cause of immunisation preventable disease in New Zealand. The current pertussis epidemic in New Zealand began in August 2011 and did not show signs of abating until May 2013. The current New Zealand immunisation schedule recommends that the first three doses of pertussis...

This report presents summary results from the 2004 survey, which includes questions on both influenza and, for the first time, pneumococcal vaccination. The influenza questions are part of the review of the National Influenza Vaccine Program for Older Australians (aged 65 years or older). The pneumococcal questions support the setting of a baseline for monitoring...

This, the third biennial report on vaccine preventable diseases and vaccine coverage in Australia, brings together the four most important national sources of routinely collected data about vaccine preventable diseases and vaccinations (deaths, notifications, hospitalisations and vaccination coverage) for all age groups between 2001 and 2002.

Pneumococcal diseases are caused by a common bacterium called Streptococcus pneumoniae (the pneumococcus). The pneumococcus bacterium has approximately 90 known serotypes, only some of which commonly cause disease. Eleven serotypes are responsible for most of the disease in infants across the globe, with seven serotypes accounting for the majority of diseases in developed countries. The...